Assessment of Textbook Oncologic Outcomes Following Proctectomy for Rectal Cancer

被引:11
作者
Naffouje, Samer A. [1 ]
Ali, Muhammed A. [2 ]
Kamarajah, Sivesh K. [2 ]
White, Bradley [3 ]
Salti, George, I [3 ,4 ]
Dahdaleh, Fadi [4 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Surg Oncol, Tampa, FL USA
[2] Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp Birmingham, Dept Surg, Birmingham, W Midlands, England
[3] Univ Illinois Hosp & Hlth Sci Syst, Dept Gen Surg, Chicago, IL USA
[4] Edward Elmhurst Hlth, Dept Surg Oncol, 120 Spalding Dr,Ste 205, Naperville, IL 60540 USA
关键词
Rectal adenocarcinoma; Textbook outcomes; COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; NEOADJUVANT CHEMORADIATION; SURGEON VOLUME; TERM OUTCOMES; COLON-CANCER; ASSOCIATION; RESECTION; SURVIVAL; CHEMORADIOTHERAPY;
D O I
10.1007/s11605-021-05213-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Outcomes of rectal adenocarcinoma vary considerably. Composite "textbook oncologic outcome" (TOO) is a single metric that estimates optimal clinical performance for cancer surgery. Methods Patients with stage II/III rectal adenocarcinoma who underwent single-agent neoadjuvant chemoradiation and proctectomy within 5-12 weeks were identified in the National Cancer Database (NCDB). TOO was defined as achievement of negative distal and circumferential resection margin (CRM), retrieval of >= 12 nodes, no 90-day mortality, and length of stay (LOS) < 75th percentile of corresponding year's range. Multivariable logistic regression was used to identify predictors of TOO. Results Among 318,225 patients, 8869 met selection criteria. Median age was 62 years (IQR 54-71), and 5550 (62.6%) were males. Low anterior resection was the most common procedure (LAR, 6,037 (68.1%) and 3084 (34.8%) were treated at a high-volume center (>= 20 rectal resections/year). TOO was achieved in 3967 patients (44.7%). Several components of TOO were achieved commonly, including negative CRM (87.4%), no 90-day mortality (98.0%), no readmission (93.0%), and no prolonged hospitalization (78.8%). Logistic regression identified increasing age, non-private insurance, low-volume centers, open approach, Black race, Charlson score >= 3, and abdominoperineal resection (APR) as predictors of failure to achieve TOO. Over time, TOOs were attained more commonly which correlated with increased minimally invasive surgery (MIS) adoption. TOO achievement was associated with improved survival. Conclusions Rectal adenocarcinoma patients achieve TOO uncommonly. Treatment at high-volume centers and MIS approach were among modifiable factors associated with TOO in this study.
引用
收藏
页码:1286 / 1297
页数:12
相关论文
共 50 条
[1]   Workload and surgeon's specialty for outcome after colorectal cancer surgery [J].
Archampong, David ;
Borowski, David ;
Wille-Jorgensen, Peer ;
Iversen, Lene H. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (03)
[2]   Rectal Cancer, Version 2.2018 Clinical Practice Guidelines in Oncology [J].
Benson, Al B., III ;
Venook, Alan P. ;
Al-Hawary, Mahmoud M. ;
Cederquist, Lynette ;
Chen, Yi-Jen ;
Ciombor, Kristen K. ;
Cohen, Stacey ;
Cooper, Harry S. ;
Deming, Dustin ;
Engstrom, Paul F. ;
Grem, Jean L. ;
Grothey, Axel ;
Hochster, Howard S. ;
Hoffe, Sarah ;
Hunt, Steven ;
Kamel, Ahmed ;
Kirilcuk, Natalie ;
Krishnamurthi, Smitha ;
Messersmith, Wells A. ;
Meyerhardt, Jeffrey ;
Mulcahy, Mary F. ;
Murphy, James D. ;
Nurkin, Steven ;
Saltz, Leonard ;
Sharma, Sunil ;
Shibata, David ;
Skibber, John M. ;
Sofocleous, Constantinos T. ;
Stoffel, Elena M. ;
Stotsky-Himelfarb, Eden ;
Willett, Christopher G. ;
Wuthrick, Evan ;
Gregory, Kristina M. ;
Gurski, Lisa ;
Freedman-Cass, Deborah A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (07) :874-901
[3]   Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer A Systematic Review and Meta-analysis [J].
Biagi, James J. ;
Raphael, Michael J. ;
Mackillop, William J. ;
Kong, Weidong ;
King, Will D. ;
Booth, Christopher M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22) :2335-2342
[4]   Validation of the 6th Edition AJCC Pancreatic Cancer Staging System - Report from the National Cancer Database [J].
Bilimoria, Karl Y. ;
Bentrem, David J. ;
Ko, Clifford Y. ;
Ritchey, Jamie ;
Stewart, Andrew K. ;
Winchester, David P. ;
Talamonti, Mark S. .
CANCER, 2007, 110 (04) :738-744
[5]   A Randomized Trial of Laparoscopic versus Open Surgery for Rectal Cancer [J].
Bonjer, H. Jaap ;
Deijen, Charlotte L. ;
Abis, Gabor A. ;
Cuesta, Miguel A. ;
van der Pas, Martijn H. G. M. ;
de lange-de Klerk, Elly S. M. ;
Lacy, Antonio M. ;
Bemelman, Willem A. ;
Andersson, John ;
Angenete, Eva ;
Rosenberg, Jacob ;
Fuerst, Alois ;
Haglind, Eva .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (14) :1324-1332
[6]   Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study [J].
Bosset, Jean-Francois ;
Calais, Gilles ;
Mineur, Laurent ;
Maingon, Philippe ;
Stojanovic-Rundic, Suzana ;
Bensadoun, Rene-Jean ;
Bardet, Etienne ;
Beny, Alexander ;
Ollier, Jean-Claude ;
Bolla, Michel ;
Marchal, Dominique ;
Van Laethem, Jean-Luc ;
Klein, Vincent ;
Giralt, Jordi ;
Clavere, Pierre ;
Glanzmann, Christoph ;
Cellier, Patrice ;
Collette, Laurence .
LANCET ONCOLOGY, 2014, 15 (02) :184-190
[7]   Evaluating the Current Status of Rectal Cancer Care in the US: Where We Stand at the Start of the Commission on Cancer's National Accreditation Program for Rectal Cancer [J].
Brady, Justin T. ;
Xu, Zhaomin ;
Scarberry, Kelly B. ;
Saad, Amin ;
Fleming, Fergal J. ;
Remzi, Feza H. ;
Wexner, Steven D. ;
Winchester, David P. ;
Monson, John R. T. ;
Lee, Lawrence ;
Dietz, David W. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (05) :881-890
[8]   Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data [J].
Breugom, Anne J. ;
Swets, Marloes ;
Bosset, Jean-Francois ;
Collette, Laurence ;
Sainato, Aldo ;
Cionini, Luca ;
Glynne-Jones, Rob ;
Counsell, Nicholas ;
Bastiaannet, Esther ;
van den Broek, Colette B. M. ;
Liefers, Gerrit-Jan ;
Putter, Hein ;
van de Velde, Cornelis J. H. .
LANCET ONCOLOGY, 2015, 16 (02) :200-207
[9]   Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials [J].
Bujko, K. ;
Glynne-Jones, R. ;
Bujko, M. .
ANNALS OF ONCOLOGY, 2010, 21 (09) :1743-1750
[10]   Association Between Hospital and Surgeon Volume and Rectal Cancer Surgery Outcomes in Patients With Rectal Cancer Treated Since 2000: Systematic Literature Review and Meta-analysis [J].
Chioreso, Catherine ;
Del Vecchio, Natalie ;
Schweizer, Marin L. ;
Schlichting, Jennifer ;
Gribovskaja-Rupp, Irena ;
Charlton, Mary E. .
DISEASES OF THE COLON & RECTUM, 2018, 61 (11) :1320-1332